Clinical Trials Browser

Observational × Neuroendocrine Tumor Grade 3 × surufatinib × Clear all

NCT05973968 2023-08-04

Surufatinib in G3 Neuroendocrine Tumors

Neuroendocrine Tumor Grade 3